Overview

A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to demonstrate a lack of effect of multiple doses of GSK189075 on the PK of an oral contraceptive pill in healthy female subjects. To estimate the effects of GSK189075 on hormonal levels and on birth control.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Contraceptive Agents
Contraceptives, Oral
Contraceptives, Oral, Combined
Mestranol
Norethindrone
Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination
Norinyl